CompletedNCT04192266

Estrogen and Fear in PTSD

Medication studyAges 18–45United States

The study in practice

Understand this study

Listed age limits: 18 years to 45 years.

Listed locations: Philadelphia, United States · Houston, United StatesSee all locations and recruitment
Activities: Medication described in the protocol · Placebo comparator
Compensation: Payment and expense reimbursement have not been verified.

Study clarity

Study start dateStarted: June 24, 2020

Recruitment status: Completed
Enrollment listed in the registry: 83
Sponsor: The University of Texas Health Science Center, Houston
Sponsor type: University
Study type: Drug
Intervention type: Psychotherapy / behavioral intervention, Medication / drug
Study phase: Phase 3
Locations: United States
Age range: From 18 Years to 45 Years
Official registry ID: NCT04192266
Official title: Show the full official title
A Randomized, Double-blind Placebo-controlled Multi-center Study of Identifying Neural Mechanisms of PTSD Symptom Reduction Induced by Combined Estrogen and Prolonged Exposure Therapy

Completed

Philadelphia · Houston

FAQ

Who is behind this study?

The study sponsor is The University of Texas Health Science Center, Houston, a university.

Did this study involve medication?

Yes. The study involved medication, including Estradiol and Placebo oral tablet.

Who was this study for?

Listed age limits: 18 years to 45 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.